Medication for treating primary disease of purpura haemorhagica and preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 陕西郝其军制药股份有限公司
- Publication Date
- 2005-01-12
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
Technical field:
[0001] The invention relates to a medicine for treating idiopathic thrombocytopenic purpura, specifically a Chinese patent medicine prepared from traditional Chinese medicines, and also relates to a preparation method of the medicine. technical background:
[0002] Idiopathic thrombocytopenic purpura (ITP) is a common clinical acquired autoimmune blood disease, the main features are thrombocytopenia and skin and mucous membrane bleeding. Its annual incidence rate is about 4.8 per 100,000 people, and the incidence rate of children is higher than that of adults. In recent years, the number of elderly patients has an increasing trend. The clinical features of ITP are different between children and adults. The former has a more acute onset, more severe symptoms, and generally responds better to treatment, while the latter has a slower onset, poor response to treatment, and some are refractory.
[0003] At present, the drug treatment of this disease at home and ...